2022. Reply to criticism of the paper: Critical reappraisal of Balangero chrysotile and mesothelioma risk by Magnani et al. . Epidemiology, Biostatistics, and Public Health. 12, 3 (May 2022). DOI:https://doi.org/10.2427/11448.